NCT06466824

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Observational Study on the Outcome of Patients With Primary Immune Thrombocytopenia (ITP) Who Underwent Splenectomy After January 1st, 2010

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 157 (estimated)
• Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Retrospective data collection on ITP patients who underwent splenectomy from 01/01/2010 to 12/31/2022. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

Detailed description

Observational, longitudinal, retrospective study on ITP patients. Patients with ITP who underwent splenectomy from 01/01/2010 to 12/31/2022 will be enrolled. All useful data will be collected exclusively through consultation of outpatient medical records. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

Conditions

• Primary Immune Thrombocytopenia

Timeline

• Start date: 2024-09-01
• Primary completion: 2025-03-01
• Completion: 2025-03-01
• First posted: 2024-06-20
• Last updated: 2024-06-20